Macroscale delivery systems for molecular and cellular payloads (original) (raw)

• Dang, J. M. & Leong, K. W. Natural polymers for gene delivery and tissue engineering. Adv. Drug Deliv. Rev. 58, 487–499 (2006).
  Article CAS Google Scholar
• Folkman, J., Long, D. M. & Rosenbaum, R. Silicone rubber: A new diffusion property useful for general anesthesia. Science 154, 148–149 (1966).
  Article CAS Google Scholar
• Hoffman, A. S. The origins and evolution of 'controlled' drug delivery systems. J. Control. Release 132, 153–163 (2008).
  Article CAS Google Scholar
• Langer, R. & Folkman, J. Polymers for the sustained release of proteins and other macromolecules. Nature 263, 797–800 (1976).
  Article CAS Google Scholar
• Kanasty, R., Dorkin, R. J., Vegas, A. & Anderson, D. Delivery materials for siRNA therapeutics. Nature Mater. 12, 967–977 (2013).
  Article CAS Google Scholar
• Irvine, D. J., Swartz, M. A. & Szeto, G. L. Engineering synthetic vaccines using cues from natural immunity. Nature Mater. 12, 978–990 (2013).
  Article CAS Google Scholar
• Mura, S., Nicolas, J. & Couvreur, P. Stimuli-responsive nanocarriers for drug delivery. Nature Mater. 12, 991–1003 (2013).
  Article CAS Google Scholar
• Roseman, T. J. Release of steroids from a silicone polymer. J. Pharm. Sci. 61, 46–50 (1972).
  Article CAS Google Scholar
• Pitt, C. G., Gratzl, M. M., Jeffcoat, A. R., Zweidinger, R. & Schindler, A. Sustained drug delivery systems II: Factors affecting release rates from poly(ɛ-caprolactone) and related biodegradable polyesters. J. Pharm. Sci. 68, 1534–1538 (1979).
  Article CAS Google Scholar
• Langer, R. Polymeric delivery systems for controlled drug release. Chem. Eng. Comm. 6, 1–48 (1980).
  Article CAS Google Scholar
• Augst, A., Kong, H. & Mooney, D. Alginate hydrogels as biomaterials. Macromol. Biosci. 6, 623–633 (2006).
  Article CAS Google Scholar
• Young, S., Wong, M., Tabata, Y. & Mikos, A. G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release 109, 256–274 (2005).
  Article CAS Google Scholar
• Bhattarai, N., Gunn, J. & Zhang, M. Chitosan-based hydrogels for controlled, localized drug delivery. Adv. Drug Deliv. Rev. 62, 83–99 (2010).
  Article CAS Google Scholar
• Janmey, P. A., Winer, J. P. & Weisel, J. W. Fibrin gels and their clinical and bioengineering applications. J. R. Soc. Interface 6, 1–10 (2009).
  Article CAS Google Scholar
• Uhrich, K. E., Cannizzaro, S. M., Langer, R. S. & Shakesheff, K. M. Polymeric systems for controlled drug release. Chem. Rev. 99, 3181–3198 (1999).
  Article CAS Google Scholar
• Tanaka, H., Matsumura, M. & Veliky, I. A. Diffusion characteristics of substrates in Ca-alginate gel beads. Biotechnol. Bioeng. 26, 53–58 (1984).
  Article CAS Google Scholar
• Lin, C-C. & Metters, A. T. Hydrogels in controlled release formulations: network design and mathematical modeling. Adv. Drug Deliv. Rev. 58, 1379–1408 (2006).
  Article CAS Google Scholar
• Am Ende, M. T. & Peppas, N. A. Transport of ionizable drugs and proteins in crosslinked poly(acrylic acid) and poly(acrylic acid-co-2-hydroxyethyl methacrylate) hydrogels. I. Polymer characterization. J. Appl. Polym. Sci. 59, 673–685 (1996).
  Article CAS Google Scholar
• Am Ende, M. T. & Peppas, N. A. Transport of ionizable drugs and proteins in crosslinked poly(acrylic acid) and poly(acrylic acid-co-2-hydroxyethyl methacrylate) hydrogels. II. Diffusion and release studies. J. Control. Release 48, 47–56 (1997).
  Article CAS Google Scholar
• Silva, A. K. A., Richard, C., Bessodes, M., Scherman, D. & Merten, O-W. Growth factor delivery approaches in hydrogels. Biomacromolecules 10, 9–18 (2009).
  Article CAS Google Scholar
• Peppas, N. A., Bures, P., Leobandung, W. & Ichikawa, H. Hydrogels in pharmaceutical formulations. Eur. J. Pharm. Biopharm. 50, 27–46 (2000).
  Article CAS Google Scholar
• Peppas, N. A., Hilt, J. Z., Khademhosseini, A. & Langer, R. Hydrogels in biology and medicine: From molecular principles to bionanotechnology. Adv. Mater. 18, 1345–1360 (2006).
  Article CAS Google Scholar
• Lee, K., Silva, E. A. & Mooney, D. J. Growth factor delivery-based tissue engineering: General approaches and a review of recent developments. J. R. Soc. Interface 8, 153–170 (2011).
  Article CAS Google Scholar
• Gupta, P., Vermani, K. & Garg, S. Hydrogels: From controlled release to pH-responsive drug delivery. Drug Discov. Today 7, 569–579 (2002).
  Article CAS Google Scholar
• Hoare, T. R. & Kohane, D. S. Hydrogels in drug delivery: Progress and challenges. Polymer 49, 1993–2007 (2008).
  Article CAS Google Scholar
• Lu, S. & Anseth, K. S. Photopolymerization of multilaminated poly(HEMA) hydrogels for controlled release. J. Control. Release 57, 291–300 (1999).
  Article CAS Google Scholar
• Galaev, I. Y. & Mattiasson, B. 'Smart' polymers and what they could do in biotechnology and medicine. Trends Biotechnol. 17, 335–340 (1999).
  Article CAS Google Scholar
• Miyata, T., Asami, N. & Uragami, T. A reversibly antigen-responsive hydrogel. Nature 399, 766–769 (1999).
  Article CAS Google Scholar
• Zhang, J. & Peppas, N. A. Synthesis and characterization of pH- and temperature-sensitive poly(methacrylic acid)/poly(_N_-isopropylacrylamide) interpenetrating polymeric networks. Macromolecules 33, 102–107 (2000).
  Article CAS Google Scholar
• Wang, N. X. & von Recum, H. A. Affinity-based drug delivery. Macromol. Biosci. 11, 321–332 (2011).
  Article CAS Google Scholar
• Borselli, C. et al. Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc. Natl Acad. Sci. USA 107, 3287–3292 (2010).
  Article CAS Google Scholar
• Pike, D. B. et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 27, 5242–5251 (2006).
  Article CAS Google Scholar
• Thatiparti, T. R., Shoffstall, A. J. & von Recum, H. A. Cyclodextrin-based device coatings for affinity-based release of antibiotics. Biomaterials 31, 2335–2347 (2010).
  Article CAS Google Scholar
• Conrad, H. E. Heparin-Binding Proteins (Academic, 1997).
  Google Scholar
• Silva, E. A. & Mooney, D. J. Effects of VEGF temporal and spatial presentation on angiogenesis. Biomaterials 31, 1235–1241 (2010).
  Article CAS Google Scholar
• Freeman, I., Kedem, A. & Cohen, S. The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins. Biomaterials 29, 3260–3268 (2008).
  Article CAS Google Scholar
• Stockwell, A. F., Davis, S. S. & Walker, S. E. In vitro evaluation of alginate gel systems as sustained release drug delivery systems. J. Control. Release 3, 167–175 (1986).
  Article CAS Google Scholar
• Vlatakis, G., Andersson, L. I., Müller, R. & Mosbach, K. Drug assay using antibody mimics made by molecular imprinting. Nature 361, 645–647 (1993).
  Article CAS Google Scholar
• Hiratani, H., Mizutani, Y. & Alvarez-Lorenzo, C. Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities. Macromol. Biosci. 5, 728–733 (2005).
  Article CAS Google Scholar
• Alvarez-Lorenzo, C. & Concheiro, A. Molecularly imprinted polymers for drug delivery. J. Chromatogr. B 804, 231–245 (2004).
  Article CAS Google Scholar
• Rachkov, A. & Minoura, N. Towards molecularly imprinted polymers selective to peptides and proteins. The epitope approach. Biochim. Biophys. Acta 1544, 255–266 (2001).
  Article CAS Google Scholar
• Richardson, T. P., Peters, M. C., Ennett, A. B. & Mooney, D. J. Polymeric system for dual growth factor delivery. Nature Biotechnol. 19, 1029–1034 (2001).
  Article CAS Google Scholar
• Ishihara, M. et al. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization. J. Biomed. Mater. Res. A 64, 551–559 (2003).
  Article CAS Google Scholar
• Wood, K. C., Chuang, H. F., Batten, R. D., Lynn, D. M. & Hammond, P. T. Controlling interlayer diffusion to achieve sustained, multiagent delivery from layer-by-layer thin films. Proc. Natl Acad. Sci. USA 103, 10207–10212 (2006).
  Article CAS Google Scholar
• Hammond, P. T. Form and function in multilayer assembly: New applications at the nanoscale. Adv. Mater. 16, 1271–1293 (2004).
  Article CAS Google Scholar
• Macdonald, M. L. et al. Tissue integration of growth factor-eluting layer-by-layer polyelectrolyte multilayer coated implants. Biomaterials 32, 1446–1453 (2011).
  Article CAS Google Scholar
• Leong, K. W., Brott, B. C. & Langer, R. Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. J. Biomed. Mater. Res. 19, 941–955 (1985).
  Article CAS Google Scholar
• Wood, K. C. et al. Electroactive controlled release thin films. Proc. Natl Acad. Sci. USA 105, 2280–2285 (2008).
  Article CAS Google Scholar
• Kost, J., Leong, K. & Langer, R. Ultrasound-enhanced polymer degradation and release of incorporated substances. Proc. Natl Acad. Sci. USA 86, 7663–7666 (1989).
  Article CAS Google Scholar
• Liu, T-Y., Hu, S-H., Liu, T-Y., Liu, D-M. & Chen, S-Y. Magnetic-sensitive behavior of intelligent ferrogels for controlled release of drug. Langmuir 22, 5974–5978 (2006).
  Article CAS Google Scholar
• Santini, J. T., Cima, M. J. & Langer, R. A controlled-release microchip. Nature 397, 335–338 (1999).
  Article CAS Google Scholar
• Pitt, W. G., Husseini, G. A. & Staples, B. J. Ultrasonic drug delivery: A general review. Expert Opin. Drug Deliv. 1, 37–56 (2004).
  Article CAS Google Scholar
• Zhao, X. et al. Active scaffolds for on-demand drug and cell delivery. Proc. Natl Acad. Sci. USA 108, 67–72 (2011).
  Article CAS Google Scholar
• Murdan, S. Electro-responsive drug delivery from hydrogels. J. Control. Release 92, 1–17 (2003).
  Article CAS Google Scholar
• Sawahata, K., Hara, M., Yasunaga, H. & Osada, Y. Electrically controlled drug delivery system using polyelectrolyte gels. J. Control. Release 14, 253–262 (1990).
  Article CAS Google Scholar
• Farra, R. et al. First-in-human testing of a wirelessly controlled drug delivery microchip. Sci. Transl. Med. 4, 122ra21 (2012).
  Article CAS Google Scholar
• Lutolf, M. P. & Hubbell, J. A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nature Biotechnol. 23, 47–55 (2005).
  Article CAS Google Scholar
• Kuhl, P. R. & Griffith-Cima, L. G. Tethered epidermal growth factor as a paradigm for growth factor–induced stimulation from the solid phase. Nature Med. 2, 1022–1027 (1996).
  Article CAS Google Scholar
• Mann, B. K., Schmedlen, R. H. & West, J. L. Tethered-TGF-β increases extracellular matrix production of vascular smooth muscle cells. Biomaterials 22, 439–444 (2001).
  Article CAS Google Scholar
• Liu, H-W., Chen, C-H., Tsai, C-L., Lin, I-H. & Hsiue, G-H. Heterobifunctional poly(ethylene glycol)-tethered bone morphogenetic protein-2-stimulated bone marrow mesenchymal stromal cell differentiation and osteogenesis. Tissue Eng. 13, 1113–1124 (2007).
  Article CAS Google Scholar
• Schense, J. C. & Hubbell, J. A. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. Bioconjug. Chem. 10, 75–81 (1999).
  Article CAS Google Scholar
• Hubbell, J. A. Bioactive biomaterials. Curr. Opin. Biotechnol. 10, 123–129 (1999).
  Article CAS Google Scholar
• Ito, Y. Covalently immobilized biosignal molecule materials for tissue engineering. Soft Matter 4, 46–56 (2008).
  Article CAS Google Scholar
• Sakiyama-Elbert, S. E., Panitch, A. & Hubbell, J. A. Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J. 15, 1300–1302 (2001).
  Article CAS Google Scholar
• Schmoekel, H. G. et al. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol. Bioeng. 89, 253–262 (2005).
  Article CAS Google Scholar
• BCC Research Advanced Drug Delivery Systems: Technologies and Global Markets (2011); http://www.bccresearch.com
• Markets and Markets Global Biomaterial Market (2010–2015) (2011); http://www.marketsandmarkets.com
• Centers for Disease Control and Prevention (CDC) Number of All-listed Procedures for Discharges from Short-Stay Hospitals, by Procedure Category and Sex: United States, 2010. (2011); available via http://go.nature.com/Xu3rNU
• Moses, J. W. et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. New Engl. J. Med. 349, 1315–1323 (2003).
  Article CAS Google Scholar
• Stone, G. W. et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. New Engl. J. Med. 350, 221–231 (2004).
  Article CAS Google Scholar
• Hwang, C. W., Wu, D. & Edelman, E. R. Physiological transport forces govern drug distribution for stent-based delivery. Circulation 104, 600–605 (2001).
  Article CAS Google Scholar
• Burt, H. M. & Hunter, W. L. Drug-eluting stents: A multidisciplinary success story. Adv. Drug Deliv. Rev. 58, 350–357 (2006).
  Article CAS Google Scholar
• Stefanini, G. G. et al. Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial. Lancet 378, 1940–1948 (2011).
  Article CAS Google Scholar
• Byrne, R. A. et al. Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial. J. Am. Coll. Cardiol. 58, 1325–1331 (2011).
  Article Google Scholar
• Joner, M. et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J. Am. Coll. Cardiol. 48, 193–202 (2006).
  Article Google Scholar
• Dudek, D. et al. Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial. EuroIntervention 7, 1060–1061 (2012).
  Article Google Scholar
• Wieneke, H. et al. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits. Catheter Cardiovasc. Interv. 60, 399–407 (2003).
  Article Google Scholar
• Kollum, M. et al. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis. Catheter Cardiovasc. Interv. 64, 85–90 (2005).
  Article Google Scholar
• Tang, C. et al. The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents. J. Vasc. Surg. 53, 461–471 (2011).
  Article Google Scholar
• Boden, S. D., Zdeblick, T. A., Sandhu, H. S. & Heim, S. E. The use of rhBMP-2 in interbody fusion cages: Definitive evidence of osteoinduction in humans. A preliminary report. Spine 25, 376–381 (2000).
  Article CAS Google Scholar
• Govender, S. et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J. Bone Joint Surg. Am. 84, 2123–2134 (2002).
  Article Google Scholar
• McKay, W. F., Peckham, S. M. & Badura, J. M. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE® Bone Graft). Int. Orthop. 31, 729–734 (2007).
  Article Google Scholar
• White, A. P. et al. Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion. Int. Orthop. 31, 735–741 (2007).
  Article Google Scholar
• Carragee, E. J., Hurwitz, E. L. & Weiner, B. K. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: Emerging safety concerns and lessons learned. Spine J. 11, 471–491 (2011).
  Article Google Scholar
• Simmons, C. A., Alsberg, E., Hsiong, S., Kim, W. J. & Mooney, D. J. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35, 562–569 (2004).
  Article CAS Google Scholar
• Hosseinkhani, H., Hosseinkhani, M., Khademhosseini, A. & Kobayashi, H. Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold. J. Control. Release 117, 380–386 (2007).
  Article CAS Google Scholar
• Yamamoto, M., Takahashi, Y. & Tabata, Y. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. Biomaterials 24, 4375–4383 (2003).
  Article CAS Google Scholar
• Turing, A. M. The chemical basis of morphogenesis. Phil. Trans. R. Soc. Lond. B 641, 33–72 (1952).
  Google Scholar
• Yuen, W. W., Du, N. R., Chan, C. H., Silva, E. A. & Mooney, D. J. Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones. Proc. Natl Acad. Sci. USA 107, 17933–17938 (2010).
  Article CAS Google Scholar
• Bragdon, C. R., Jasty, M., Greene, M., Rubash, H. E. & Harris, W. H. Biologic fixation of total hip implants. Insights gained from a series of canine studies. J. Bone Joint Surg. Am. 86-A Suppl 2, 105–117 (2004).
  Article Google Scholar
• Simion, M. et al. Vertical ridge augmentation using an equine block infused with recombinant human platelet-derived growth factor-BB: A histologic study in a canine model. Int. J. Periodont. Restor. Dent. 29, 245–255 (2009).
  Google Scholar
• Simion, M., Rocchietta, I., Kim, D., Nevins, M. & Fiorellini, J. Vertical ridge augmentation by means of deproteinized bovine bone block and recombinant human platelet-derived growth factor-BB: A histologic study in a dog model. Int. J. Periodont. Restor. Dent. 26, 415–423 (2006).
  Google Scholar
• Jaklenec, A., Stamp, A., Deweerd, E., Sherwin, A. & Langer, R. Progress in the tissue engineering and stem cell industry: “Are we there yet?” Tissue Eng. B Rev. 18, 155–166 (2012).
  Article Google Scholar
• Langer, R. & Vacanti, J. Tissue engineering. Science 260, 920–926 (1993).
  Article CAS Google Scholar
• Mooney, D. J. & Vandenburgh, H. Cell delivery mechanisms for tissue repair. Cell Stem Cell 2, 205–213 (2008).
  Article CAS Google Scholar
• Hofmann, M. et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111, 2198–2202 (2005).
  Article Google Scholar
• Toma, C. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93–98 (2002).
  Article Google Scholar
• Fisher, R. A. & Strom, S. C. Human hepatocyte transplantation: Worldwide results. Transplantation 82, 441–449 (2006).
  Article Google Scholar
• Kim, B. S., Baez, C. E. & Atala, A. Biomaterials for tissue engineering. World J. Urol. 18, 2–9 (2000).
  Article CAS Google Scholar
• Malafaya, P. B., Silva, G. A. & Reis, R. L. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv. Drug Deliv. Rev. 59, 207–233 (2007).
  Article CAS Google Scholar
• Sittinger, M., Hutmacher, D. W. & Risbud, M. V. Current strategies for cell delivery in cartilage and bone regeneration. Curr. Opin. Biotechnol. 15, 411–418 (2004).
  Article CAS Google Scholar
• Chastain, S. R., Kundu, A. K., Dhar, S., Calvert, J. W. & Putnam, A. J. Adhesion of mesenchymal stem cells to polymer scaffolds occurs via distinct ECM ligands and controls their osteogenic differentiation. J. Biomed. Mater. Res. 78, 73–85 (2006).
  Article CAS Google Scholar
• Cooper, M. L. et al. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh. Biomaterials 12, 243–248 (1991).
  Article CAS Google Scholar
• Mooney, D. J. et al. Biodegradable sponges for hepatocyte transplantation. J. Biomed. Mater. Res. 29, 959–965 (1995).
  Article CAS Google Scholar
• Cao, Y., Vacanti, J. P., Paige, K. T., Upton, J. & Vacanti, C. A. Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast. Reconstr. Surg. 100, 297–302 (1997).
  Article CAS Google Scholar
• Barrera, D. A., Zylstra, E., Lansbury, P. T. & Langer, R. Synthesis and RGD peptide modification of a new biodegradable copolymer: poly(lactic acid-co-lysine). J. Am. Chem. Soc. 115, 11010–11011 (1993).
  Article CAS Google Scholar
• Hersel, U., Dahmen, C. & Kessler, H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials 24, 31–31 (2003).
  Article CAS Google Scholar
• Smetana, K. Cell biology of hydrogels. Biomaterials 14, 1046–1050 (1993).
  Article CAS Google Scholar
• Rowley, J. A., Madlambayan, G. & Mooney, D. J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20, 45–53 (1999).
  Article CAS Google Scholar
• Alsberg, E. Engineering growing tissues. Proc. Natl Acad. Sci. USA 99, 12025–12030 (2002).
  Article CAS Google Scholar
• Alsberg, E., Anderson, K. W., Albeiruti, A., Franceschi, R. T. & Mooney, D. J. Cell-interactive alginate hydrogels for bone tissue engineering. J. Dent. Res. 80, 2025–2029 (2001).
  Article CAS Google Scholar
• Harris, L., Kim, B. & Mooney, D. Open pore biodegradable matrices formed with gas foaming. J. Biomed. Mater. Res. 42, 396–402 (1998).
  Article CAS Google Scholar
• Mooney, D. J., Baldwin, D. F., Suh, N. P., Vacanti, J. P. & Langer, R. Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials 17, 1417–1422 (1996).
  Article CAS Google Scholar
• O'Brien, F. J., Harley, B. A., Yannas, I. V. & Gibson, L. J. The effect of pore size on cell adhesion in collagen–GAG scaffolds. Biomaterials 26, 433–441 (2005).
  Article CAS Google Scholar
• Mikos, A. G., Sarakinos, G., Leite, S. M., Vacanti, J. P. & Langer, R. Laminated three-dimensional biodegradable foams for use in tissue engineering. Biomaterials 14, 323–330 (1993).
  Article CAS Google Scholar
• Mikos, A. G. et al. Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J. Biomed. Mater. Res. 27, 183–189 (1993).
  Article CAS Google Scholar
• Giordano, R. A. et al. Mechanical properties of dense polylactic acid structures fabricated by three dimensional printing. J. Biomater. Sci. Polym. Edn 8, 63–75 (1997).
  Article Google Scholar
• Mironov, V., Boland, T., Trusk, T., Forgacs, G. & Markwald, R. R. Organ printing: Computer-aided jet-based 3D tissue engineering. Trends Biotechnol. 21, 157–161 (2003).
  Article CAS Google Scholar
• Compton, C. C., Butler, C. E., Yannas, I. V., Warland, G. & Orgill, D. P. Organized skin structure is regenerated in vivo from collagen–GAG Matrices seeded with autologous keratinocytes. J. Investig. Dermatol. 110, 908–916 (1998).
  Article CAS Google Scholar
• Atala, A., Oberpenning, F., Meng, J. & Yoo, J. J. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nature Biotechnol. 17, 149–155 (1999).
  Article CAS Google Scholar
• Nicodemus, G. D. & Bryant, S. J. Cell encapsulation in biodegradable hydrogels for tissue engineering applications. Tissue Eng. B Rev. 14, 149–165 (2008).
  Article CAS Google Scholar
• Boontheekul, T., Kong, H. & Mooney, D. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials 26, 2455–2465 (2005).
  Article CAS Google Scholar
• O'Sullivan, E. S., Vegas, A., Anderson, D. G. & Weir, G. C. Islets transplanted in immunoisolation devices: a review of the progress and the challenges that remain. Endocr. Rev. 32, 827–844 (2011).
  Article CAS Google Scholar
• Sun, Y., Ma, X., Zhou, D., Vacek, I. & Sun, A. M. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J. Clin. Investig. 98, 1417–1422 (1996).
  Article CAS Google Scholar
• Chang, T. M. S. Artificial liver support based on artificial cells with emphasis on encapsulated hepatocytes. Artif. Organs 16, 71–74 (2008).
  Article Google Scholar
• Lutolf, M. P., Gilbert, P. M. & Blau, H. M. Designing materials to direct stem-cell fate. Nature 462, 433–441 (2009).
  Article CAS Google Scholar
• Brown, K. V. et al. Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release. Tissue Eng. A 17, 1735–1746 (2011).
  Article CAS Google Scholar
• Kolambkar, Y. M. et al. An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials 32, 65–74 (2011).
  Article CAS Google Scholar
• Lucas, P. A. et al. Ectopic induction of cartilage and bone by water-soluble proteins from bovine bone using a polyanhydride delivery vehicle. J. Biomed. Mater. Res. 24, 901–911 (1990).
  Article CAS Google Scholar
• Hedberg, E. L. et al. Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo. J. Biomed. Mater. Res. 72A, 343–353 (2005).
  Article CAS Google Scholar
• Loeser, R. F. Aging and osteoarthritis: the role of chondrocyte senescence and aging changes in the cartilage matrix. Osteoarthr. Cartilage 17, 971–979 (2009).
  Article CAS Google Scholar
• Steadman, J. R. et al. Outcomes of microfracture for traumatic chondral defects of the knee: Average 11-year follow-up. Arthroscopy 19, 477–484 (2003).
  Article Google Scholar
• Breinan, H. A., Martin, S. D., Hsu, H.-P. & Spector, M. Healing of canine articular cartilage defects treated with microfracture, a type-II collagen matrix, or cultured autologous chondrocytes. J. Orthop. Res. 18, 781–789 (2000).
  Article CAS Google Scholar
• Nöth, U., Steinert, A. F. & Tuan, R. S. Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nature Clin. Pract. Rheumatol. 4, 371–380 (2008).
  Article CAS Google Scholar
• Gille, J. et al. Mid-term results of autologous matrix-induced chondrogenesis for treatment of focal cartilage defects in the knee. Knee Surg. Sports Traumatol. Arthrosc. 18, 1456–1464 (2010).
  Article CAS Google Scholar
• Lee, C. H. et al. Regeneration of the articular surface of the rabbit synovial joint by cell homing: A proof of concept study. Lancet 376, 440–448 (2010).
  Article CAS Google Scholar
• Huang, Q., Goh, J. C. H., Hutmacher, D. W. & Lee, E. H. In vivo mesenchymal cell recruitment by a scaffold loaded with transforming growth factor β1 and the potential for in situ chondrogenesis. Tissue Eng. 8, 469–482 (2002).
  Article CAS Google Scholar
• Driver, V. R., Fabbi, M., Lavery, L. A. & Gibbons, G. The costs of diabetic foot: the economic case for the limb salvage team. J. Am. Podiat. Med. Assoc. 100, 335–341 (2010).
  Article Google Scholar
• Lynch, S. E., Nixon, J. C., Colvin, R. B. & Antoniades, H. N. Role of platelet-derived growth factor in wound healing: Synergistic effects with other growth factors. Proc. Natl Acad. Sci. USA 84, 7696–7700 (1987).
  Article CAS Google Scholar
• Metcalfe, A. D. & Ferguson, M. W. J. Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration. J. R. Soc. Interface 4, 413–437 (2007).
  Article CAS Google Scholar
• Yannas, I. V. & Burke, J. F. Design of an artificial skin. I. Basic design principles. J. Biomed. Mater. Res. 14, 65–81 (1980).
  Article CAS Google Scholar
• Pandit, A., Ashar, R. & Feldman, D. The effect of TGF-beta delivered through a collagen scaffold on wound healing. J. Investig. Surg. 12, 89–100 (1999).
  Article CAS Google Scholar
• Kawai, K., Suzuki, S., Tabata, Y., Ikada, Y. & Nishimura, Y. Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials 21, 489–499 (2000).
  Article CAS Google Scholar
• Gu, D. Adenovirus encoding human platelet-derived growth factor-B delivered in collagen exhibits safety, biodistribution, and immunogenicity profiles favorable for clinical use. Mol. Ther. 9, 699–711 (2004).
  Article CAS Google Scholar
• Huang, Y-C., Kaigler, D., Rice, K. G., Krebsbach, P. H. & Mooney, D. J. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J. Bone Miner. Res. 20, 848–857 (2004).
  Article CAS Google Scholar
• Kofron, M. D. & Laurencin, C. T. Bone tissue engineering by gene delivery. Adv. Drug Deliv. Rev. 58, 555–576 (2006).
  Article CAS Google Scholar
• Peterson, B. et al. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng. 11, 120–129 (2005).
  Article CAS Google Scholar
• Sugiyama, O. et al. Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol. Ther. 11, 390–398 (2005).
  Article CAS Google Scholar
• Geiger, F. et al. VEGF producing bone marrow stromal cells (BMSC) enhance vascularization and resorption of a natural coral bone substitute. Bone 41, 516–522 (2007).
  Article CAS Google Scholar
• Jabbarzadeh, E. et al. Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: A combined gene therapy–cell transplantation approach. Proc. Natl Acad. Sci. USA 105, 11099–11104 (2008).
  Article CAS Google Scholar
• Peng, H. et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J. Clin. Investig. 110, 751–759 (2002).
  Article CAS Google Scholar
• Blumenthal, B. et al. Polyurethane scaffolds seeded with genetically engineered skeletal myoblasts: A promising tool to regenerate myocardial function. Artif. Organs 34, E46–E54 (2010).
  Article CAS Google Scholar
• Egaña, J. T. et al. Use of human mesenchymal cells to improve vascularization in a mouse model for scaffold-based dermal regeneration. Tissue Eng. A 15, 1191–1200 (2008).
  Article Google Scholar
• Park, H., Temenoff, J. S., Tabata, Y., Caplan, A. I. & Mikos, A. G. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials 28, 3217–3227 (2007).
  Article CAS Google Scholar
• Koffler, J. et al. Improved vascular organization enhances functional integration of engineered skeletal muscle grafts. Proc. Natl Acad. Sci. USA 108, 14789–14794 (2011).
  Article CAS Google Scholar
• Kneser, U. et al. Long-term differentiated function of heterotopically transplanted hepatocytes on three-dimensional polymer matrices. J. Biomed. Mater. Res. 47, 494–503 (1999).
  Article CAS Google Scholar
• Bruns, H. et al. Injectable liver: A novel approach using fibrin gel as a matrix for culture and intrahepatic transplantation of hepatocytes. Tissue Eng. 11, 1718–1726 (2005).
  Article CAS Google Scholar
• Vandenburgh, H. et al. Tissue-engineered skeletal muscle organoids for reversible gene therapy. Hum. Gene Ther. 7, 2195–2200 (1996).
  Article CAS Google Scholar
• Borselli, C., Cezar, C. A., Shvartsman, D., Vandenburgh, H. H. & Mooney, D. J. The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration. Biomaterials 32, 8905–8914 (2011).
  Article CAS Google Scholar
• Silva, E. A., Kim, E-S., Kong, H. J. & Mooney, D. J. Material-based deployment enhances efficacy of endothelial progenitor cells. Proc. Natl Acad. Sci. USA 105, 14347–14352 (2008).
  Article CAS Google Scholar
• Ali, O. A., Huebsch, N., Cao, L., Dranoff, G. & Mooney, D. J. Infection-mimicking materials to program dendritic cells in situ. Nature Mater. 8, 151–158 (2009).
  Article CAS Google Scholar
• Ali, O. A., Emerich, D., Dranoff, G. & Mooney, D. J. In situ regulation of DC subsets and T cells mediates tumor regression in mice. Sci. Transl. Med. 1, 8ra19 (2009).
  Article CAS Google Scholar
• Kong, H., Lee, K. & Mooney, D. Decoupling the dependence of rheological/mechanical properties of hydrogels from solids concentration. Polymer 43, 6239–6246 (2002).
  Article CAS Google Scholar
• Chenite, A. et al. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 21, 2155–2161 (2000).
  Article CAS Google Scholar
• Liu, X., Jin, X. & Ma, P. X. Nanofibrous hollow microspheres self-assembled from star-shaped polymers as injectable cell carriers for knee repair. Nature Mater. 10, 398–406 (2011).
  Article CAS Google Scholar